Natamycin

那他霉素

Report date: 2026/03/06 20:02:51

Base Information

Drug NameNatamycin
Drug Alias Name纳它链霉素natamycine纳他霉素natamycinumnatamicina +[16] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionErgosterol binders
TargetsErgosterol
Therapy Area/IndicationsBlepharitisKeratitisConjunctivitis +[4] 
Global Approved IndicationsBlepharitisKeratitisConjunctivitis +[4] 
Approved Indications in ChinaBlepharitisKeratitisConjunctivitis
Original Approved Country/TerritoryUnited States
Original Approved Date1978/10/30
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHarrow Eye LLC
China Registration ClassN/A

Develop Information

Active CompaniesHarrow Eye LLCAlcon Laboratories Inc
Inactive CompaniesN/A
Active IndicationsBlepharitisKeratitisConjunctivitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA01AB10A07AA03D01AA02 +[5] 
Related LinksWikipediaDrugBankKEGG